<DOC>
	<DOCNO>NCT03066193</DOCNO>
	<brief_summary>This investigator-initiated proof concept study purpose examine safety , tolerability feasibility Dronabinol ( synthetic Î”9-THC ) PEA treatment adult Tourette syndrome .</brief_summary>
	<brief_title>Efficacy Therapeutic Combination Dronabinol PEA Tourette Syndrome</brief_title>
	<detailed_description>The investigator propose 12-week , investigator-initiated , open-label trial therapeutic combination Dronabinol PEA 18 adult Tourette syndrome . Participants receive Dronabinol PEA combination duration trial . The goal pilot study ( 1 ) provide initial safety , feasibility tolerability data Dronabinol PEA TS population ( 2 ) provide data order make inform decision regard appropriate sample size design large clinical trial prove efficacy ( i.e . sample size trial duration large efficacy trial Dronabinol/PEA combination TS ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Tourette Syndrome</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<mesh_term>Palmidrol</mesh_term>
	<criteria>Adult 1860 year age Meet DSM5 criterion diagnosis Tourette syndrome Significant current tic symptom : YGTSS total tic score great equal 22 baseline On stable psychiatric medication regimen minimum 4 week prior begin trial Accepted method birth control Comorbid bipolar disorder , psychotic disorder , substance use disorder , developmental disorder intellectual disability ( IQ &lt; 70 ) Recent change ( less 4 week ) medication potential effect tic severity ( alpha2 agonist ( guanfacine , clonidine prazosin ) , SSRIs , clomipramine , naltrexone , lithium , anxiolytic , topiramate , baclofen etc. ) . Medication change define include dose change medication discontinuation . Recent change behavioral treatment Tourette syndrome comorbid condition ( i.e . OCD ) within last 4 week initiation behavioral therapy tic within last 12 week . Taking comedications ( counter prescription ) , food supplements/additives drug interaction dronabinol PEA . Positive pregnancy test drug screen test History cannabis dependence Significant Medical Comorbidity History hypersensitivity cannabinoid sesame oil</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Motor tic</keyword>
	<keyword>Vocal tic</keyword>
	<keyword>Cannabinoids</keyword>
	<keyword>Dronabinol</keyword>
	<keyword>PEA</keyword>
	<keyword>Palmitoylethanolamide</keyword>
	<keyword>Tourettes</keyword>
	<keyword>TS</keyword>
</DOC>